# Aquestive Therapeutics, Inc.: Form DEF 14A, filed Apr 24, 2026

- Company: [Aquestive Therapeutics, Inc.](/companies/aqst.md) (CIK 1398733)
- Form: DEF 14A
- Filed: 2026-04-24
- Accepted by EDGAR: Apr 24, 2026, 17:00 ET
- Period: 2026-06-10
- Accession: 0001140361-26-016757
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1398733/000114036126016757/ny20064249x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1398733/000114036126016757/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1398733/000114036126016757/ny20064249x1_def14a.htm

Filed Apr 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-016757. Last ingested by Listed: Nov 5, 2026, 18:09 ET. No prices; not investment advice.